The Directorate General of Drug Administration (DGDA) today approved emergency use of Pfizer mRNA Covid-19 vaccine in the country.
The regulator has given Emergency Use Authorization ( EUA) after all necessary examinations by the committee, a press release, signed by Maj Gen Md Mahbubur Rahman, Director General of DGDA said.
Produced by Pfizer Manufacturing Belgium NV, this is the fourth Covid-19 vaccine approved for emergency use in Bangladesh.
The other approved vaccines are: Covishield produced by Serum Institute of India, Sputnik V produced by Generium Joint Stock Company of Russia, and Sinopharm produced by Beijing Institute of Biological Products Co. Ltd of China.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.